Clinical Trials

Drug Development Drug Efficacy Randomized Controlled Trials Phase 3 Trials Patient Care Research Studies Drug Safety Randomized Trials Phase 2 Trials Oncology Drug Trials Evidence-Based Medicine Cancer Research Experimental Drugs Vaccine Efficacy Research Gene Therapy Pharmaceuticals Vaccine Development Cancer Treatment FDA Approval Nutrition Palliative Care Immunotherapy Trials Phase 3 Studies Innovative Treatments Exercise Programs Regulatory Approval Therapeutic Targets Pharmacology Pharmaceutical Research Patient Outcomes Experimental Treatments Immunotherapy Vagus Nerve Stimulation Regenerative Medicine Psychiatry Trial Limitations Treatment Approaches Medication Chronic Spontaneous Urticaria Insider Trading SELECT Trial Patient Recruitment Kidney Outcomes Trials Pediatric Clinical Trials NHS LoDoCo2 Trial Medical Records Drug Efficacy Studies Late-Stage Trials UCLH Trial Cancer Treatment Trials Study Design Decentralization Human Trials Patient Selection Hormone Therapy CRISPR Treatment Prevention Methods Oral Immunotherapy Results Food Allergy Treatment Illegal Practices Patient Inclusion Adult Treatment Allergy Treatments Endometriosis Psychedelic Research Treatment Methods Cardiovascular Health HIV Research Efficacy Patient Eligibility HCV Screening Alzheimer's Treatment Regulatory Affairs Efficacy Studies Digital Health Financial Irregularities Medical Ethics Stem Cell Therapy Nutritional Supplements Patient Access Preclinical Research Phase I/II Trials Obesity Treatments Medical Research Accessibility ESSENCE Trial Ethics in Medicine Data Services Data Management Research Methodologies Mobile Health Applications Phase 2 Studies Public Health Mobile Applications Pharmacokinetics Meta-Analysis

FDA Grants National Priority Voucher to J&J’s Tecvayli–Darzalex Combo in Multiple Myeloma

The voucher shortens FDA review to one to two months post‑submission.

Terns’ TERN-701 Shows Strong CML Responses in CARDINAL, Setting 320 mg and 500 mg Phase 2 Doses

Meta-Analysis Finds Laughing Gas Delivers Fast, Short-Lived Relief in Depression

Sorfequiline Outperforms Standard TB Regimens in Phase 2 Trial

Randomized Trial Finds Metformin Dulls Key Gains From Exercise

Daily Coffee Lowers AFib Recurrence in Randomized Trial

Self-Guided Hypnosis Halves Menopausal Hot Flashes, JAMA Trial Finds

Intellia Pauses Phase 3 Trials of CRISPR Therapy After Severe Liver Event

Adjuvant Pembrolizumab Cuts Risk of Distant Metastases in Merkel Cell Carcinoma at ESMO 2025

Intuitive Surgical Heads Into Q3 Report With Bullish Calls Despite Margin Concerns

Putting a Price on Pain: Study Finds Monetary Measure Beats 0–10 Scale

Arecor and Sequel to Co-Develop AT278 With Twiist AID for High-Dose Diabetes Care

Canadian Team Advances CHAMPS App Trial for Safer Cannabis Use After First-Episode Psychosis

Semnur Goes Public via Denali SPAC, Unveils $100 Million Bitcoin Stock Sale Plan

EU Regulators Back Uplizna as First Treatment for IgG4‑Related Disease

Med Safety App Boosts Adverse Drug Reaction Reports by 73% in Uganda Trial

Triple-Dose Semaglutide Outperforms Standard Regimen in Weight-Loss Trials

Personalized Brain Stimulation Speeds Depression Relief in UCLA Trial

Constipation Drug Lubiprostone Slows Kidney Function Decline in Phase II CKD Trial

USC Study Unveils Non-Invasive Cerebrovascular Index With High Accuracy for Alzheimer’s Detection